12 May, 09:49 - Indian

SENSEX 81527.6 (2.61)

Nifty 50 24611.65 (2.51)

Nifty Bank 55050.2 (2.71)

Nifty IT 36981.3 (3.07)

Nifty Midcap 100 54717.1 (2.81)

Nifty Next 50 64322.1 (2.87)

Nifty Pharma 20694.8 (-1.79)

Nifty Smallcap 100 16610.15 (3.26)

12 May, 09:49 - Global

NIKKEI 225 37517.35 (0.04)

HANG SENG 23065 (0.86)

S&P 5772.75 (1.45)

LOGIN HERE

companylogoJupiter Life Line Hospitals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543980 | NSE Symbol : JLHL | ISIN : INE682M01012 | Industry : Healthcare |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
05-May-2025 09-May-2025 Accounts Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2025 ,inter alia, to consider and approve Notice of the Board Meeting to be held on Friday, May 09, 2025 Jupiter Life Line Hospitals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2025. Recommendation of a dividend @ 10 % i.e. ? 1/- per equity share of face value of Rs.10/- each for the FY 2024-25, subject to approval of members at the ensuing Annual General Meeting. The dividend, if approved by the members in the ensuing Annual General Meeting will be paid on or before 30 days from the date of Annual General Meeting. The Book Closure and Record Date for dividend purpose will be intimated in due course (As Per BSE Announcement Dated on :09.05.2025)
03-Feb-2025 07-Feb-2025 Quarterly Results Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2025 inter alia to consider and approve the Un-Audited Financial Results Along With The Limited Review Report Of The Company (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024 in accordance with Regulation 33 of the SEBI Listing Regulation. Outcome of Board meeting dated February 07, 2025 Unaudited (standalone & consolidated) financials statements for quarter and nine months ended December 31, 2024 (As per BSE Announcement Dated on 07/02/2025)
29-Oct-2024 08-Nov-2024 Quarterly Results Quarterly Results Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 ,inter alia, to consider and approve the Un-audited Financial Results along with the Limited Review Report of the Company (Standalone and Consolidated) for the quarter and half year ended September 30, 2024 in accordance with Regulation 33 of the SEBI Listing Regulation Ouctome of Board Meeting dated November 08, 2024 (As per BSE Announcement Dated on 08/11/2024)
05-Aug-2024 09-Aug-2024 Quarterly Results Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve the Un-audited Financial Results along with the Limited Review Report of the Company (Standalone and Consolidated) for the quarter ended June 30 2024 in accordance with Regulation 33 of the SEBI Listing Regulation. Unaudited Financial Results for the quarter ended June 30, 2024 Please refer the attached PDF Appointment of M/s. Varma & Varma as Internal Auditor of the Company for Financial Year 2024-25 (As per BSE Announcement Dated on 09/08/2024)
02-May-2024 10-May-2024 Accounts Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter and financial year ending on March 31 2024 in accordance with Regulation 33 of the SEBI Listing Regulation. Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 ,inter alia, to consider and approve Update on board meeting - Pursuant to Regulation 29(1)(e) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of Jupiter Life Line Hospitals Limited at its meeting scheduled to be held on Friday, May 10, 2024, shall also consider a proposal for recommendation of Final Dividend on equity shares for the Financial Year 2023- 24. (As Per BSE Announcement Dated on 07.05.2024) the Board of Directors of the Company at its Meeting held today, i.e., May 10, 2024, has considered and approved the Unaudited Financial Results for the quarter ended March 31, 2024 and Audited Financial Results of the Company for the financial year ended March 31, 2024 (both Standalone and Consolidated), along with the Auditor's Report thereon. A copy of the said Results along with the Auditors Report issued by the Statutory Auditors of the Company is enclosed. The Board has recommended a dividend of Re 1 equity shares @ 10% of the face value of shares, subject to the approval of shareholders at the ensuing Annual General Meeting. Appointment of Secretarial Auditor for Financial Year 2024-25 Please refer to the attached PDF (As Per BSE Announcement Dated on 10.05.2024)
01-Feb-2024 09-Feb-2024 Quarterly Results Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Un-audited Financial Results along with the Limited Review Report of the Company (Standalone and Consolidated) for the quarter and nine month ended December 31 2023 in accordance with Regulation 33 of the SEBI Listing Regulation. this is to inform you that pursuant to Reg 30, 33 and Schedule III of the SEBI LODR, 2015, the Board of Directors of the Company at its Meeting held today, i.e., February 9, 2023, has inter-alia Considered and approved the Un-audited Financial Results (Standalone and Consolidated) of the Company, for the quarter and nine month ended December 31, 2023 along with the Limited Review Report. Please refer to the attached PDF file (As per BSE Announcement Dated on 09/02/2024)
02-Nov-2023 10-Nov-2023 Quarterly Results Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve AS PER THE REGULATION 29 THE BOARD MEETING INTIMATION IS GIVE FOR THE MEETING SCHEDULED TO BE HELD ON NOVEMBER 10 2023 In furtherance to our intimation dated November 2, 2023, this is to inform you that pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,the Board of Directors of the Company at its Meeting held today, i.e., November 10, 2023 has considered and approved the Unaudited Financial Results of the Company, for the quarter and half year ended September 30 ,2023 along with the Limited Review Report and noted the Independent Auditors' Review Reports with unmodified opinions on the said quarterly and half yearly financial results. A copy of the said results along with the Limited Review Report issued by the Statutory Auditors of the company are enclosed herewith for your record. The Board Meeting commenced at 3:00 P.M and concluded at 4.15 P.M. Please refer to the attached PDF (As Per BSE Announcement Dated on 10.11.2023)
30-Sep-2023 06-Oct-2023 Quarterly Results Jupiter Life Line Hospitals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/10/2023 inter alia to consider and approve PURSUANT TO REGULATION 33 (3)(J) AND REGULATION 29 OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATION AND DISCLOSURE REQUIREMENT) REGULATION 2015 AS AMENDED FROM TIME TO TIME (LISTING REGULATION) WE WRITE TO INFORM YOU THAT A MEETING OF THE BOARD OF DIRECTORS OF THE COMPANY IS SCHEDULE TO BE HELD ON OCTOBER 6 2023 TO CONSIDER AND APPROVE THE UNAUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT OF THE COMPANY FOR THE QUATER ENDED JUNE 30 2023 UNDER REGULATION 33 OF THE SEBI LISTING REGULATION. In furtherance to our intimation dated 30th September, 2023, this is to inform you that pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,the Board of Directors of the Company at its Meeting held today, i.e.,6th October, 2023 has considered and approved the Unaudited Financial Results of the Company, for the quarter ended 30th June,2023 along with the Limited Review Report and noted the Independent Auditors' Review Reports with unmodified opinions on the said quarterly financial results. A copy of the said results along with the Limited Review Report issued by the Statutory Auditors of the company are enclosed herewith for your record. The Board Meeting commenced at 3:00 P.M and concluded at 4.15 P.M. Please refer to the enclosed PDF (As Per BSE Announcement Dated on 06/10/2023) Newspaper Publication for Unaudited Financial Results( Standalone and Consolidated) for quarter ended 30th June,2023 (As Per BSE Announcement dated on 08.10.2023)

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +